195 related articles for article (PubMed ID: 9101588)
1. Increased expression of cholecystokinin-A receptor mRNA in pancreas and cholecystokinin-B receptor mRNA in oxyntic mucosa after porta-caval shunting in rats.
Nylander AG; von Friesen CP; Monstein HJ; Yamada H; Chen D; Boketoft A; Håkanson R
Pharmacol Toxicol; 1997 Mar; 80(3):147-51. PubMed ID: 9101588
[TBL] [Abstract][Full Text] [Related]
2. The method of administration of cholecystokinin determines the effects evoked in the pancreas.
Ohlsson B; Borg K; Rehfeld JF; Axelson J; Sundler F
Pancreas; 2001 Jul; 23(1):94-101. PubMed ID: 11451154
[TBL] [Abstract][Full Text] [Related]
3. Effects of antrectomy or porta-caval shunting on the histamine-storing endocrine-like cells in oxyntic mucosa of rat stomach. A fluorescence histochemical, electron microscopic and chemical study.
Häkanson R; Larsson LI; Liedberg G; Oscarson J; Sundler F; Vang J
J Physiol; 1976 Aug; 259(3):785-800. PubMed ID: 957264
[TBL] [Abstract][Full Text] [Related]
4. Time-course of deactivation of rat stomach ECL cells following cholecystokinin B/gastrin receptor blockade.
Ding XQ; Lindström E; Håkanson R
Br J Pharmacol; 1997 Sep; 122(1):1-6. PubMed ID: 9298521
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study.
Monstein HJ; Nylander AG; Salehi A; Chen D; Lundquist I; Håkanson R
Scand J Gastroenterol; 1996 Apr; 31(4):383-90. PubMed ID: 8726308
[TBL] [Abstract][Full Text] [Related]
6. Effects of portacaval shunt on the rat stomach.
Ekelund M; Håkanson R; Holmin T; Oscarson J; Rehfeld JF; Sundler F; Westrin P
Acta Physiol Scand; 1985 Jul; 124(3):437-47. PubMed ID: 4050476
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
Zhou W; Povoski SP; Bell RH
J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
[TBL] [Abstract][Full Text] [Related]
8. The trophic response of rat pancreas to sulfated cholecystokinin-8 is dose- and time-dependent and not affected by vagotomy or atropine.
Nylander AG; Chen D; Ding XQ; Norlén P; Håkanson R
Pharmacol Toxicol; 1997 Mar; 80(3):142-6. PubMed ID: 9101587
[TBL] [Abstract][Full Text] [Related]
9. The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas.
Ohlsson B; Borg K; Rehfeld JF; Ihse I; Axelson J
Int J Pancreatol; 1998 Dec; 24(3):211-8. PubMed ID: 9873956
[TBL] [Abstract][Full Text] [Related]
10. Transient agonist-induced regulation of the cholecystokinin-A and cholecystokinin-B receptor mRNA levels in rat pancreatic acinar AR42J cells.
Günther R; Carstens OC; Schmidt WE; Fölsch UR
Pancreatology; 2003; 3(1):47-54. PubMed ID: 12649564
[TBL] [Abstract][Full Text] [Related]
11. Continuous infusion of cholecystokinin leads to down-regulation of the cholecystokinin-A receptor in the rat pancreas.
Ohlsson B; Borg K; Mulder H; Rehfeld JF; Axelson J; Sundler F
Scand J Gastroenterol; 2000 Jun; 35(6):612-8. PubMed ID: 10912661
[TBL] [Abstract][Full Text] [Related]
12. Enterochromaffin-like cells in rat stomach respond to short-term infusion of high doses of cholecystokinin but not to long-term, sustained, moderate hyperCCKemia caused by continuous cholecystokinin infusion or pancreaticobiliary diversion.
Nylander AG; Chen D; Lilja I; Axelson J; Ihse I; Rehfeld JF; Sundler F; Håkanson R
Scand J Gastroenterol; 1993 Jan; 28(1):73-9. PubMed ID: 8430275
[TBL] [Abstract][Full Text] [Related]
13. Functional impairment of the individual rat stomach ECL cell in response to sustained hypergastrinemia.
Kimura K; Chen D; Lindström E; Yamada H; Zhao CM; Håkanson R
Regul Pept; 1997 Oct; 72(2-3):69-77. PubMed ID: 9652979
[TBL] [Abstract][Full Text] [Related]
14. Effect of cholecystokinin and 16,16-dimethyl prostaglandin E2 on RNA and DNA of gastric and duodenal mucosa.
Johnson LR; Guthrie P
Gastroenterology; 1976 Jan; 70(1):59-65. PubMed ID: 1245285
[TBL] [Abstract][Full Text] [Related]
15. Altered influence of CCK-B/gastrin receptors on HDC expression in ECL cells after neoplastic transformation.
Kölby L; Wängberg B; Ahlman H; Modlin IM; Theodorsson E; Nilsson O
Regul Pept; 1999 Dec; 85(2-3):115-23. PubMed ID: 10651065
[TBL] [Abstract][Full Text] [Related]
16. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
[TBL] [Abstract][Full Text] [Related]
17. Reversibility of cholecystokinin-B/gastrin receptor blockade: a study of the gastrin-ECL cell axis in the rat.
Norlén P; Lindström E; Ding XQ; Kitano M; Håkanson R
Pharmacol Toxicol; 1999 Apr; 84(4):159-64. PubMed ID: 10227066
[TBL] [Abstract][Full Text] [Related]
18. The effects of antagonists of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
Dembiński A; Warzecha Z; Konturek SJ; Cai RZ; Schally AV
J Physiol Pharmacol; 1991 Jun; 42(2):195-209. PubMed ID: 1664265
[TBL] [Abstract][Full Text] [Related]
19. A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control.
Dornonville de la Cour C; Björkqvist M; Sandvik AK; Bakke I; Zhao CM; Chen D; Håkanson R
Regul Pept; 2001 Jun; 99(2-3):141-50. PubMed ID: 11384775
[TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
